abstract |
The present invention provides a method for increasing neurogenesis in the brain by administering an inhibitor of anaplastic lymphoma kinase (ALK), the treatment of cognitive dysfunction and depression disorders by administering an inhibitor of ALK, an assay for determining inhibitors of ALK, and inhibitors of ALK. |